You just read:

Prometic's Plasminogen (Ryplazim™) granted orphan drug designation for the treatment of idiopathic pulmonary fibrosis (IPF)

News provided by

ProMetic Life Sciences Inc.

Dec 18, 2017, 09:46 EST